Eleven Therapeutics

Eleven Therapeutics is a biotechnology company developing next-generation RNA therapeutics by combining combinatorial chemistry with artificial intelligence to map the vast chemical space of possible RNA molecules.

The company's platform is designed to precisely program RNA-based drugs that silence disease-causing genes at their root cause, extending durability beyond earlier RNAi approaches.

Its UK operations are based at the Cambridge Biomedical Campus, forming one of three collaborative research hubs alongside Boston, US and Tel Aviv, Israel.